PPAR-ACTIVATING COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

A compound represented by the following formula (1): (wherein each of R 1 and R 2 , which may be identical to or different from each other, represents a hydrogen atom, a methyl group, or an ethyl group; each of R 3a , R 3b , R 4a , and R 4b , which may be identical to or different from each other, r...

Full description

Saved in:
Bibliographic Details
Main Authors ARAKI, TAKAAKI, OKUDA, AYUMU, TOMA, TSUTOMU, ABE, KAZUTOYO, NISHIKAWA, MASAHIRO, OZAWA, HIDEFUMI, YAMAZAKI, YUKIYOSHI, ODA, SOICHI
Format Patent
LanguageEnglish
Published 16.03.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A compound represented by the following formula (1): (wherein each of R 1 and R 2 , which may be identical to or different from each other, represents a hydrogen atom, a methyl group, or an ethyl group; each of R 3a , R 3b , R 4a , and R 4b , which may be identical to or different from each other, represents a hydrogen atom, a halogen atom, a nitro group, a hydroxyl group, a C 1-4 alkyl group, a trifluoromethyl group, a C 1-4 alkoxy group, a C 1-4 alkylcarbonyloxy group, a di-C 1-4 alkylamino group, a C 1-4 alkylsulfonyloxy group, a C 1-4 alkylsulfonyl group, a C 1-4 alkylsulfinyl group, or a C 1-4 alkylthio group, or R 3a and R 3b , or R 4a and R 4b may be linked together to form an alkylenedioxy group; X represents an oxygen atom, a sulfur atom, or N-R 5 (R 5 represents a hydrogen atom, a C 1-4 alkyl group, a C 1-4 alkylsulfonyl group, or a C 1-4 alkyloxycarbonyl group); Y represents an oxygen atom, S(O) 1 (1 is a number of 0 to 2), a carbonyl group, a carbonylamino group, an aminocarbonyl group, a sulfonylamino group, or an aminosulfonyl group; Z represents CH or N; n is a number of 1 to 6; and m is a number of 2 to 6) or a salt thereof; and therapeutic drugs containing any of such a compound or salt.
AbstractList A compound represented by the following formula (1): (wherein each of R 1 and R 2 , which may be identical to or different from each other, represents a hydrogen atom, a methyl group, or an ethyl group; each of R 3a , R 3b , R 4a , and R 4b , which may be identical to or different from each other, represents a hydrogen atom, a halogen atom, a nitro group, a hydroxyl group, a C 1-4 alkyl group, a trifluoromethyl group, a C 1-4 alkoxy group, a C 1-4 alkylcarbonyloxy group, a di-C 1-4 alkylamino group, a C 1-4 alkylsulfonyloxy group, a C 1-4 alkylsulfonyl group, a C 1-4 alkylsulfinyl group, or a C 1-4 alkylthio group, or R 3a and R 3b , or R 4a and R 4b may be linked together to form an alkylenedioxy group; X represents an oxygen atom, a sulfur atom, or N-R 5 (R 5 represents a hydrogen atom, a C 1-4 alkyl group, a C 1-4 alkylsulfonyl group, or a C 1-4 alkyloxycarbonyl group); Y represents an oxygen atom, S(O) 1 (1 is a number of 0 to 2), a carbonyl group, a carbonylamino group, an aminocarbonyl group, a sulfonylamino group, or an aminosulfonyl group; Z represents CH or N; n is a number of 1 to 6; and m is a number of 2 to 6) or a salt thereof; and therapeutic drugs containing any of such a compound or salt.
Author OZAWA, HIDEFUMI
OKUDA, AYUMU
ABE, KAZUTOYO
ARAKI, TAKAAKI
ODA, SOICHI
TOMA, TSUTOMU
YAMAZAKI, YUKIYOSHI
NISHIKAWA, MASAHIRO
Author_xml – fullname: ARAKI, TAKAAKI
– fullname: OKUDA, AYUMU
– fullname: TOMA, TSUTOMU
– fullname: ABE, KAZUTOYO
– fullname: NISHIKAWA, MASAHIRO
– fullname: OZAWA, HIDEFUMI
– fullname: YAMAZAKI, YUKIYOSHI
– fullname: ODA, SOICHI
BookMark eNrjYmDJy89L5WRwDwhwDNJ1dA7xDHMM8fRzV3D29w3wD_VzUXAE4gAPxyBfR2fX0BBPZ0cfiFywZ4invx-Q7Rfi6OkH0hLs6OvKw8CalphTnMoLpbkZFNxcQ5w9dFML8uNTiwsSk1PzUkviPbwNDSyNLc1NHQ2NiVACAMMTLj0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID HK1093975A1
GroupedDBID EVB
ID FETCH-epo_espacenet_HK1093975A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:57:17 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HK1093975A13
Notes Application Number: HK20060114278
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070316&DB=EPODOC&CC=HK&NR=1093975A1
ParticipantIDs epo_espacenet_HK1093975A1
PublicationCentury 2000
PublicationDate 20070316
PublicationDateYYYYMMDD 2007-03-16
PublicationDate_xml – month: 03
  year: 2007
  text: 20070316
  day: 16
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies KOWA CO., LTD
RelatedCompanies_xml – name: KOWA CO., LTD
Score 2.6732635
Snippet A compound represented by the following formula (1): (wherein each of R 1 and R 2 , which may be identical to or different from each other, represents a...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PPAR-ACTIVATING COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070316&DB=EPODOC&locale=&CC=HK&NR=1093975A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-L8ogfprUjtx9ZDkSxt1zn6wdaO3UaztbBLN7aK_77vdR960UPgkZBHEvLLS17yfgF4ER36trowFRUng6ITFLtCfVPUYp5pusgyKyfXQBCafqp_TI1pA5aHWJiaJ_SrJkdERM0R71W9Xq9_nFhO_bZy-yqWmLV69xLbkQ-nY2JjN2WnZ7tx5ERc5tz2h3I4sok1yeoYDA9KJ7SLJpp9d9KjoJT1b4viXcJpjMrK6goaedmCc374eK0FZ8H-vhvFPfS219CPYzZS6M3HhCWDsC_xKIijNHQkhin22Shg3E0T4jfYlY0H5H5COUzYIKQqYxa4NyB5bsJ9BVs0O_Z-5g-PbdduoVmuyvwOpHxhmVnX6ubEX44GJlvgzl8YBM9CE5ZoQ_tPNff_lD3Axc57qSmq-QjNavOZP6HZrcRzPWDftfeANA
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokbwawez22Lm2GCHxZRusAnrFhiEG1mhS7gMIjP--76OD73ooclLmzZt019f3-vrrwDPvC2_rc4sTcfFoLUkFDtcf9X0bJEaLZ6mtpCugZBZ_qT1PjNnFVgd3sKUPKFfJTkiImqBeC_K_Xrz48Ryy9jK7QtfYdb6rZc4rnqwjiUbu6W6XceLIzeiKqWOP1DZyJGsSXbbJGgonbTRIiwtpWlXPkrZ_NYovQs4jbGxvLiEisjrUKOHj9fqcBbu77tR3ENvewX9OCYjTcZ8TEkSsL5CozCOJsxVCKbYJ6OQUG-SSH6DXdk4kO4nlFlCAiarjEnoXYPS8xLqa9ij-XH0c39w7LtxA9V8nYtbUMTSttKO3RGSvxwVTLrEkz83JTwzg9u8AY0_m2n-U_YENT8Jh_NhwAZ3cL7zZBqabt1Dtfj4FA-oggv-WE7eN9l5gx4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PPAR-ACTIVATING+COMPOUND+AND+PHARMACEUTICAL+COMPOSITION+CONTAINING+SAME&rft.inventor=ARAKI%2C+TAKAAKI&rft.inventor=OKUDA%2C+AYUMU&rft.inventor=TOMA%2C+TSUTOMU&rft.inventor=ABE%2C+KAZUTOYO&rft.inventor=NISHIKAWA%2C+MASAHIRO&rft.inventor=OZAWA%2C+HIDEFUMI&rft.inventor=YAMAZAKI%2C+YUKIYOSHI&rft.inventor=ODA%2C+SOICHI&rft.date=2007-03-16&rft.externalDBID=A1&rft.externalDocID=HK1093975A1